Profile

Identity, professional record and current appointments.

Overview

Professional record at a glance

A concise summary of information supported by the cited public sources. Missing information is treated as unknown, not as a negative finding.

Current roles
22 current organizations shown on this profile
Board positions
22 supported by public sources, 0 supplied by the profile owner
Committee roles
4Roles supported by the sources cited on this profile
Qualifications
Not establishedNo qualification is currently confirmed by the cited sources

Professional narrative

About

Mark Smith is a practicing physician and professor of clinical medicine at UCSF since 1994. He brings an impressive background marrying active medical practice and business development, with experience as founding President and CEO of the California HealthCare Foundation and deep understanding of U.S. healthcare policy trends.

Sources are shown with the information they support.

Current roles

Appointments & responsibilities

Board appointments

Director

A. O. Smith (NYSE: AOS)

Jan 1, 2001 – Present

Independence: Independent

Source effective: 2026-03-04 · Observed: 2026-03-23T08:01:00.692+00:00

confirmedView source

Governance

Board appointments, committee responsibilities and disclosed relationships.

Committee appointments across companies

Structured records are unavailable. This does not establish that no records exist.

Board and advisory record

Board service

Sources are shown with each role, education record, or credential.

Director

Jazz Pharmaceuticals plc

2020-01-01 · current

Confirmed by public sourceView source

Director

A. O. Smith

2001-01-01 · current

Confirmed by public sourceView source

Connections

Explore the roles, education and affiliations published in this record.

A. O. Smith

Open A. O. Smith profile →

Director at A. O. Smith

2001-01-01 → End not stated

current · source reported

Observed: 2026-09-24

A. O. SmithA. O. SmithJazz Pharmaceutica…Jazz Pharmaceuticals plcMark D. Smith

Dashed lines mark past roles. Select a connection to see its dates and sources.

Relationship map

Connected through the public record

Direct relationships from verified facts and published résumé records. Private connections are excluded.

Direct public links only

Only published affiliations are shown here. Private relationships require authorized access.

Experience

Career history, education, credentials and public contributions.

Published record

Featured coverage

Selected publications and public sources used to establish this profile. Inclusion records provenance; it is not an endorsement.

Source 1 · Sec FilingAOS DEF 14A executive officersSupports AI and ML experience, Cybersecurity experience, Executive company, Executive title, Technology background.Open sourceSource 2 · Sec FilingJAZZ DEF 14A director slateSupports AI and ML experience, Board role, Committee assignments, Executive company, Executive title, Cybersecurity experience, Technology background.Open source

Basis

Identifiers, sources, dates and record limitations.

Identifiers

Alpha ID
alpha:person:mark-d-smith
Record version
public-0

Published evidence records

9 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.

  1. AOS DEF 14A executive officers

    sec filing · Source published: Mar 4, 2026 · Retrieved: May 4, 2026

    Supports 5 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at A. O. Smith Corporation · Claim reviewed: May 4, 2026
    • Executive title: Executive title: Nominating and Governance Committee Member / Director · Claim reviewed: May 4, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  2. A. O. Smith Corporation director board source

    sec filing · Source published: Mar 4, 2026 · Retrieved: May 3, 2026

    Supports 3 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of A. O. Smith Corporation · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  3. AOS DEF 14A director slate

    sec filing · Source published: Mar 4, 2026 · Retrieved: May 15, 2026

    Supports 2 claims
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Nominating/Governance, Personnel and Compensation · Claim reviewed: May 15, 2026

  4. Open source

    sec proxy · Source published: Mar 4, 2026 · Retrieved: Mar 23, 2026

    Supports 1 claim
    • Professional Role: Director at A. O. Smith · Claim reviewed: May 16, 2026

  5. JAZZ DEF 14A director slate

    sec filing · Source published: Jun 6, 2025 · Retrieved: May 16, 2026

    Supports 7 claims
    • AI and ML experience: AI and ML experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Board role: Board role: Director · Claim reviewed: May 16, 2026
    • Committee assignments: Committee assignments: Nominating Committee, SMC · Claim reviewed: May 16, 2026
    • Cybersecurity experience: Cybersecurity experience: not identified in the cited filing · Claim reviewed: May 16, 2026
    • Executive company: Executive at University of California, San Francisco · Claim reviewed: May 1, 2026
    • Executive title: Executive title: Professor of Clinical Medicine · Claim reviewed: May 1, 2026
    • Technology background: Technology background: not identified in the cited filing · Claim reviewed: May 16, 2026

  6. Jazz Pharmaceuticals director board source

    sec filing · Source published: Jun 6, 2025 · Retrieved: May 3, 2026

    Supports 4 claims
    • Board independence: Independent director · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of A. O. Smith Corporation · Claim reviewed: May 3, 2026
    • Board membership: Serves on the board of Jazz Pharmaceuticals · Claim reviewed: May 3, 2026
    • Committee assignments: No committee assignment disclosed in the cited filing · Claim reviewed: May 3, 2026

  7. Open source

    sec proxy · Source published: Jun 6, 2025 · Retrieved: May 1, 2026

    Supports 1 claim
    • Professional Role: Director at Jazz Pharmaceuticals plc · Claim reviewed: May 16, 2026

  8. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of Jazz Pharmaceuticals · Claim reviewed: May 3, 2026

  9. Open source

    public source · Source published: Date unavailable · Retrieved: Date unavailable

    Supports 1 claim
    • Board membership: Serves on the board of A. O. Smith Corporation · Claim reviewed: May 3, 2026

Sources

Sources and published information

Each item links to the public source used to support it. When sources disagree, the item is clearly marked for review.

AI and ML experience · CorroboratedAI and ML experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Board independence · CorroboratedIndependent directorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Board membership · CorroboratedServes on the board of A. O. Smith CorporationSupported by 3 public records3 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board membership · CorroboratedServes on the board of Jazz PharmaceuticalsSupported by 3 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
Board role · CorroboratedBoard role: DirectorSupported by 2 public records2 sources
Verification
Corroborated
Confidence
92%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · CorroboratedNo committee assignment disclosed in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
95%
Last reviewed
May 3, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

Committee assignments · Source reportedCommittee assignments: Nominating Committee, SMC1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Committee assignments · Source reportedCommittee assignments: Nominating/Governance, Personnel and Compensation1 source
Verification
Source reported
Confidence
88%
Last reviewed
May 15, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

Cybersecurity experience · CorroboratedCybersecurity experience: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive company · Source reportedExecutive at A. O. Smith Corporation1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Executive company · Source reportedExecutive at University of California, San Francisco1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Executive title · Source reportedExecutive title: Nominating and Governance Committee Member / Director1 source
Verification
Source reported
Confidence
94%
Last reviewed
May 4, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

Executive title · Source reportedExecutive title: Professor of Clinical Medicine1 source
Verification
Source reported
Confidence
85%
Last reviewed
May 1, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

Technology background · CorroboratedTechnology background: not identified in the cited filingSupported by 2 public records2 sources
Verification
Corroborated
Confidence
72%
Last reviewed
May 16, 2026
  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

  • SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

View all sources9 records
  1. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 4, 2026

    Supports: AI and ML experience · Cybersecurity experience · Executive company · Executive title · Technology background

  2. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Board independence

  3. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 15, 2026

    Supports: Board role · Committee assignments

  4. https://www.sec.gov/Archives/edgar/data/91142/000119312526089938/d79196ddef14a.htm

    Sec Proxy · Tier not stated · Reviewed Mar 23, 2026

    Supports: Director at A. O. Smith (NYSE: AOS)

  5. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 16, 2026

    Supports: AI and ML experience · Board role · Committee assignments · Executive company · Executive title · Cybersecurity experience · Technology background

  6. SEC EDGAR

    Sec Filing · Tier 3 · Reviewed May 3, 2026

    Supports: Board membership · Committee assignments · Director since · Board independence

  7. https://www.sec.gov/Archives/edgar/data/1232524/000123252425000043/jazz-20250606.htm

    Sec Proxy · Tier not stated · Reviewed May 1, 2026

    Supports: Director at Jazz Pharmaceuticals plc (NASDAQ: JAZZ)

  8. https://www.sec.gov/Archives/edgar/data/1232524/000123252425000043/jazz-20250606.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership

  9. https://www.sec.gov/Archives/edgar/data/91142/000119312526089938/d79196ddef14a.htm

    Public Source · Tier not stated · Reviewed Not stated

    Supports: Board membership